• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用混合模型方法分析日内瓦地区 SARS-CoV-2 血清学调查数据。

Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva.

机构信息

Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland.

Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland.

出版信息

Epidemics. 2022 Jun;39:100572. doi: 10.1016/j.epidem.2022.100572. Epub 2022 May 7.

DOI:10.1016/j.epidem.2022.100572
PMID:35580458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9076579/
Abstract

Serosurveys are an important tool to estimate the true extent of the current SARS-CoV-2 pandemic. So far, most serosurvey data have been analyzed with cutoff-based methods, which dichotomize individual measurements into sero-positives or negatives based on a predefined cutoff. However, mixture model methods can gain additional information from the same serosurvey data. Such methods refrain from dichotomizing individual values and instead use the full distribution of the serological measurements from pre-pandemic and COVID-19 controls to estimate the cumulative incidence. This study presents an application of mixture model methods to SARS-CoV-2 serosurvey data from the SEROCoV-POP study from April and May 2020 in Geneva (2766 individuals). Besides estimating the total cumulative incidence in these data (8.1% (95% CI: 6.8%-9.9%)), we applied extended mixture model methods to estimate an indirect indicator of disease severity, which is the fraction of cases with a distribution of antibody levels similar to hospitalized COVID-19 patients. This fraction is 51.2% (95% CI: 15.2%-79.5%) across the full serosurvey, but differs between three age classes: 21.4% (95% CI: 0%-59.6%) for individuals between 5 and 40 years old, 60.2% (95% CI: 21.5%-100%) for individuals between 41 and 65 years old and 100% (95% CI: 20.1%-100%) for individuals between 66 and 90 years old. Additionally, we find a mismatch between the inferred negative distribution of the serosurvey and the validation data of pre-pandemic controls. Overall, this study illustrates that mixture model methods can provide additional insights from serosurvey data.

摘要

血清学调查是估计当前 SARS-CoV-2 大流行真实范围的重要工具。到目前为止,大多数血清学调查数据都是使用基于截断值的方法进行分析的,该方法根据预定义的截断值将个体测量值分为血清阳性或阴性。然而,混合模型方法可以从相同的血清学调查数据中获得额外的信息。这些方法避免将个体值二分化,而是使用来自大流行前和 COVID-19 对照的血清学测量的完整分布来估计累积发病率。本研究应用混合模型方法分析了 2020 年 4 月至 5 月在日内瓦进行的 SEROCoV-POP 研究中的 SARS-CoV-2 血清学调查数据(2766 人)。除了估计这些数据中的总累积发病率(8.1%(95%CI:6.8%-9.9%))之外,我们还应用了扩展的混合模型方法来估计疾病严重程度的间接指标,即与住院 COVID-19 患者的抗体水平分布相似的病例比例。该比例在整个血清学调查中为 51.2%(95%CI:15.2%-79.5%),但在三个年龄组之间存在差异:5 至 40 岁人群为 21.4%(95%CI:0%-59.6%),41 至 65 岁人群为 60.2%(95%CI:21.5%-100%),66 至 90 岁人群为 100%(95%CI:20.1%-100%)。此外,我们发现血清学调查的推断阴性分布与大流行前对照的验证数据之间存在不匹配。总体而言,本研究表明,混合模型方法可以从血清学调查数据中提供额外的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d3/9076579/9a35d9c49683/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d3/9076579/c7dcf9f0a53c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d3/9076579/0b6e92877602/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d3/9076579/9a35d9c49683/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d3/9076579/c7dcf9f0a53c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d3/9076579/0b6e92877602/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d3/9076579/9a35d9c49683/gr3_lrg.jpg

相似文献

1
Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva.应用混合模型方法分析日内瓦地区 SARS-CoV-2 血清学调查数据。
Epidemics. 2022 Jun;39:100572. doi: 10.1016/j.epidem.2022.100572. Epub 2022 May 7.
2
Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.利用无截断方法估算存在不完善血清学检测的 SARS-CoV-2 的累积发病率。
PLoS Comput Biol. 2021 Feb 26;17(2):e1008728. doi: 10.1371/journal.pcbi.1008728. eCollection 2021 Feb.
3
Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP).普通人群对免疫和疫苗接种证书的认知:一项针对抗 SARS-CoV-2 抗体(SEROCoV-POP)血清学调查的嵌套研究。
Swiss Med Wkly. 2020 Nov 16;150:w20398. doi: 10.4414/smw.2020.20398.
4
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.镜-COVID19 队列研究:瑞士日内瓦州 SARS-CoV-2 血清学调查参与者的纵向随访。
BMJ Open. 2022 Jan 31;12(1):e055515. doi: 10.1136/bmjopen-2021-055515.
5
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.黎巴嫩的 SARS-CoV-2 抗体血清阳性率:首次全国血清学调查结果。
BMC Infect Dis. 2022 Jan 10;22(1):42. doi: 10.1186/s12879-022-07031-z.
6
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.2020 年 8 月至 9 月印度 SARS-CoV-2 抗体血清阳性率:第二次全国家庭血清学调查结果。
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
7
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.估算一般人群中 SARS-CoV-2 感染的无症状比例:荷兰全国血清学调查数据分析。
Eur J Epidemiol. 2021 Jul;36(7):735-739. doi: 10.1007/s10654-021-00768-y. Epub 2021 Jun 10.
8
Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.绘制大流行期间的消除情况:新西兰献血者中 SARS-CoV-2 的血清学调查。
Epidemiol Infect. 2021 Jul 30;149:e173. doi: 10.1017/S0950268821001643.
9
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.血清转换后再次感染严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的风险:基于人群的倾向评分匹配队列研究。
Clin Infect Dis. 2022 Mar 1;74(4):622-629. doi: 10.1093/cid/ciab495.
10
A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo, Brazil.巴西圣保罗市一个脆弱地区 18 岁及以上人群中抗严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)抗体的血清流行率调查。
PLoS One. 2021 Jul 29;16(7):e0255412. doi: 10.1371/journal.pone.0255412. eCollection 2021.

引用本文的文献

1
Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model.利用血清学数据和贝叶斯混合模型估计新冠病毒感染概率。
Sci Rep. 2024 Apr 25;14(1):9503. doi: 10.1038/s41598-024-60060-3.
2
Correcting for Antibody Waning in Cumulative Incidence Estimation From Sequential Serosurveys.从连续血清学调查中校正累积发病率估计的抗体衰减。
Am J Epidemiol. 2024 May 7;193(5):777-786. doi: 10.1093/aje/kwad226.

本文引用的文献

1
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels.通过抗体水平的混合建模来量化以前的 SARS-CoV-2 感染。
Nat Commun. 2021 Oct 26;12(1):6196. doi: 10.1038/s41467-021-26452-z.
2
Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands.社会隔离措施与严重急性呼吸综合征冠状病毒 2 血清阳性率之间的关联:荷兰全国范围内的基于人群的研究。
Clin Infect Dis. 2021 Dec 16;73(12):2318-2321. doi: 10.1093/cid/ciab264.
3
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.
血清学证据表明人类感染 SARS-CoV-2:系统评价和荟萃分析。
Lancet Glob Health. 2021 May;9(5):e598-e609. doi: 10.1016/S2214-109X(21)00026-7. Epub 2021 Mar 8.
4
Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.利用无截断方法估算存在不完善血清学检测的 SARS-CoV-2 的累积发病率。
PLoS Comput Biol. 2021 Feb 26;17(2):e1008728. doi: 10.1371/journal.pcbi.1008728. eCollection 2021 Feb.
5
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study.全国性前瞻性研究中与症状相关的严重急性呼吸综合征冠状病毒 2 抗体持续存在。
Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172.
6
How can we interpret SARS-CoV-2 antibody test results?我们该如何解读 SARS-CoV-2 抗体检测结果?
Pathog Dis. 2021 Feb 3;79(1). doi: 10.1093/femspd/ftaa069.
7
Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients.住院 COVID-19 患者中 11 种商业血清学检测 SARS-CoV-2 的性能评估。
Int J Infect Dis. 2021 Mar;104:661-669. doi: 10.1016/j.ijid.2021.01.038. Epub 2021 Jan 20.
8
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
9
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.全球 COVID-19 荟萃分析显示,男性性别是死亡和 ICU 入院的风险因素。
Nat Commun. 2020 Dec 9;11(1):6317. doi: 10.1038/s41467-020-19741-6.
10
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.评估 COVID-19 感染病死率的年龄特异性:系统评价、荟萃分析及公共政策意义。
Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.